Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 USD | -3.57% |
|
-3.57% | +6.09% |
May. 13 | Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Turnstone Biologics Corp. Announces Board Changes | CI |
Business Summary
Number of employees: 82
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 73 | 100.0 % | 19 | 100.0 % | -73.66% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 73 | 100.0 % | 19 | 100.0 % | -73.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sammy Farah
CEO | Chief Executive Officer | 51 | 15-09-30 |
Venkat Ramanan
DFI | Director of Finance/CFO | 55 | 22-01-31 |
Vijay Chiruvolu
CTO | Chief Tech/Sci/R&D Officer | 62 | 23-02-28 |
Stewart Abbot
CTO | Chief Tech/Sci/R&D Officer | 57 | 21-05-31 |
Michael Burgess
CTO | Chief Tech/Sci/R&D Officer | 61 | 17-09-30 |
Saryah Azmat
PRN | Corporate Officer/Principal | 35 | 21-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rishi Gupta
BRD | Director/Board Member | 46 | 16-09-30 |
Robert Gould
BRD | Director/Board Member | 69 | 18-12-31 |
Sammy Farah
CEO | Chief Executive Officer | 51 | 15-09-30 |
Michael Burgess
CTO | Chief Tech/Sci/R&D Officer | 61 | 17-09-30 |
Jerel Davis
CHM | Chairman | 47 | 15-09-30 |
Kanya Rajangam
BRD | Director/Board Member | 50 | 21-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,128,454 | 22,242,822 ( 96.17 %) | 0 | 96.17 % |
Company contact information
![address Turnstone Biologics Corp.(TSBX)](https://cdn.zonebourse.com/static/address/157247455.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.09% | 64.76M | |
+0.85% | 92.4B | |
-3.03% | 38.08B | |
-10.46% | 34.05B | |
+74.71% | 27.77B | |
-13.39% | 16B | |
-1.08% | 14.1B | |
-11.15% | 11.91B | |
+169.04% | 10.37B | |
-50.19% | 10.2B |
- Stock Market
- Equities
- TSBX Stock
- Company Turnstone Biologics Corp.